PEDIATRICS Vol. 105 No. 1 January 2000, pp. 14-20
Persistent Pulmonary Hypertension of the Newborn in the Era Before Nitric Oxide: Practice Variation and Outcomes
Received May 21, 1997; accepted Feb 24, 1998.
,
,,, and
From the * Case Western Reserve University, Cleveland, Ohio;
University of Texas Southwestern Medical Center, Dallas, Texas;
§ National Institute of Child Health and Human Development, Bethesda,
Maryland; University of Miami, Miami, Florida; ¶ University of
Tennessee, Memphis, Tennessee; # Stanford University, Stanford,
California; ** Biostatistics Center, George Washington University,
Washington DC; Emory University, Atlanta, Georgia; §§ Indiana
University, Indianapolis, Indiana; || University of New Mexico,
Albuquerque, New Mexico; ¶¶ Wayne State University, Detroit, Michigan;
## University of Cincinnati, Cincinnati, Ohio; *** Women & Infants
Hospital, Providence, Rhode Island; and Yale University, New
Haven, Connecticut.
Objectives. In the era before widespread use of inhaled nitric oxide, to determine the prevalence of persistent pulmonary hypertension (PPHN) in a multicenter cohort, demographic descriptors of the population, treatments used, the outcomes of those treatments, and variation in practice among centers.
Study Design. A total of 385 neonates who received 
50%
inspired oxygen and/or mechanical ventilation and had documented
evidence of PPHN (2D echocardiogram or preductal or postductal oxygen
difference) were tracked from admission at 12 Level III neonatal
intensive care units. Demographics, treatments, and outcomes were
documented.
Results. The prevalence of PPHN was 1.9 per 1000 live births (based on 71 558 inborns) with a wide variation observed among centers (.43-6.82 per 1000 live births). Neonates with PPHN were admitted to the Level III neonatal intensive care units at a mean of 12 hours of age (standard deviation: 19 hours). Wide variations in the use of all treatments studied were found at the centers. Hyperventilation was used in 65% overall but centers ranged from 33% to 92%, and continuous infusion of alkali was used in 75% overall, with a range of 27% to 93% of neonates. Other frequently used treatments included sedation (94%; range: 77%-100%), paralysis (73%; range: 33%-98%), and inotrope administration (84%; range: 46%-100%). Vasodilator drugs, primarily tolazoline, were used in 39% (range: 13%-81%) of neonates. Despite the wide variation in practice, there was no significant difference in mortality among centers. Mortality was 11% (range: 4%-33%). No specific therapy was clearly associated with a reduction in mortality. To determine whether the therapies were equivalent, neonates treated with hyperventilation were compared with those treated with alkali infusion. Hyperventilation reduced the risk of extracorporeal membrane oxygenation without increasing the use of oxygen at 28 days of age. In contrast, the use of alkali infusion was associated with increased use of extracorporeal membrane oxygenation (odds ratio: 5.03, compared with those treated with hyperventilation) and an increased use of oxygen at 28 days of age.
Conclusions. Hyperventilation and alkali infusion are not equivalent in their outcomes in neonates with PPHN. Randomized trials are needed to evaluate the role of these common therapies. Key words: pulmonary hypertension of the newborn, newborn, treatments, outcomes, practice variation.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  K. C. Young, E. Torres, K. E. Hatzistergos, D. Hehre, C. Suguihara, and J. M. Hare Inhibition of the SDF-1/CXCR4 Axis Attenuates Neonatal Hypoxia-Induced Pulmonary Hypertension Circ. Res., June 5, 2009; 104(11): 1293 - 1301. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. N. Farrow, S. Lakshminrusimha, W. J. Reda, S. Wedgwood, L. Czech, S. F. Gugino, J. M. Davis, J. A. Russell, and R. H. Steinhorn Superoxide dismutase restores eNOS expression and function in resistance pulmonary arteries from neonatal lambs with persistent pulmonary hypertension Am J Physiol Lung Cell Mol Physiol, December 1, 2008; 295(6): L979 - L987. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. McNamara, P. Murthy, C. Kantores, L. Teixeira, D. Engelberts, T. van Vliet, B. P. Kavanagh, and R. P. Jankov Acute vasodilator effects of Rho-kinase inhibitors in neonatal rats with pulmonary hypertension unresponsive to nitric oxide Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L205 - L213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Jankov, C. Kantores, J. Pan, and J. Belik Contribution of xanthine oxidase-derived superoxide to chronic hypoxic pulmonary hypertension in neonatal rats Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L233 - L245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Gamboa, D. Robbins, and Z. Saba Bleeding After Circumcision in a Newborn Receiving Sildenafil Clinical Pediatrics, December 1, 2007; 46(9): 842 - 843. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Hernandez-Diaz, L. J. Van Marter, M. M. Werler, C. Louik, and A. A. Mitchell Risk Factors for Persistent Pulmonary Hypertension of the Newborn Pediatrics, August 1, 2007; 120(2): e272 - e282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. G. Konduri, I. Bakhutashvili, A. Eis, and K. Pritchard Jr. Oxidant stress from uncoupled nitric oxide synthase impairs vasodilation in fetal lambs with persistent pulmonary hypertension Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1812 - H1820. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hinton, A. Gutsol, and S. Dakshinamurti Thromboxane hypersensitivity in hypoxic pulmonary artery myocytes: altered TP receptor localization and kinetics Am J Physiol Lung Cell Mol Physiol, March 1, 2007; 292(3): L654 - L663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Profit, M. C. McCormick, G. J. Escobar, D. K. Richardson, Z. Zheng, K. Coleman-Phox, R. Roberts, and J. A.F. Zupancic Neonatal Intensive Care Unit Census Influences Discharge of Moderately Preterm Infants Pediatrics, February 1, 2007; 119(2): 314 - 319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lakshminrusimha, J. A. Russell, S. Wedgwood, S. F. Gugino, J. A. Kazzaz, J. M. Davis, and R. H. Steinhorn Superoxide Dismutase Improves Oxygenation and Reduces Oxidation in Neonatal Pulmonary Hypertension Am. J. Respir. Crit. Care Med., December 15, 2006; 174(12): 1370 - 1377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Groves, C. A. Kuschel, and J. R. Skinner International Perspectives: The Neonatologist as an Echocardiographer NeoReviews, August 1, 2006; 7(8): e391 - e399. [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. Chambers, S. Hernandez-Diaz, L. J. Van Marter, M. M. Werler, C. Louik, K. L. Jones, and A. A. Mitchell Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn N. Engl. J. Med., February 9, 2006; 354(6): 579 - 587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Mills Depressing Observations on the Use of Selective Serotonin-Reuptake Inhibitors during Pregnancy N. Engl. J. Med., February 9, 2006; 354(6): 636 - 638. [Full Text] [PDF]
|
|
|
|
|
|
M. Hinton, L. Mellow, A. J. Halayko, A. Gutsol, and S. Dakshinamurti Hypoxia induces hypersensitivity and hyperreactivity to thromboxane receptor agonist in neonatal pulmonary arterial myocytes Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L375 - L384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. G. Konduri, J. Ou, Y. Shi, and K. A. Pritchard Jr. Decreased association of HSP90 impairs endothelial nitric oxide synthase in fetal lambs with persistent pulmonary hypertension Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H204 - H211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. N. Finer, J. W. Sun, W. Rich, E. Knodel, and K. J. Barrington Randomized, Prospective Study of Low-Dose Versus High-Dose Inhaled Nitric Oxide in the Neonate With Hypoxic Respiratory Failure Pediatrics, October 1, 2001; 108(4): 949 - 955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Pearson, S. Dawling, W. F. Walsh, J. L. Haines, B. W. Christman, A. Bazyk, N. Scott, and M. L. Summar Neonatal Pulmonary Hypertension- Urea-Cycle Intermediates, Nitric Oxide Production, and Carbamoyl-Phosphate Synthetase Function N. Engl. J. Med., June 14, 2001; 344(24): 1832 - 1838. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kuo, V. Camerini, R. Boyle, M. P. Griffin, D. Kaufman, J. Kattwinkel;, M. Walsh-Sukys, A. Faranoff, J. Verter, and L. Wright Pulmonary Hypertension-Hyperventilation Versus Alkali Infusion Pediatrics, February 1, 2001; 107(2): 452 - 452. [Full Text]
|
|
|
|
|
|
Committee on Fetus and Newborn Use of Inhaled Nitric Oxide Pediatrics, August 1, 2000; 106(2): 344 - 345. [Abstract] [Full Text]
|
|
